Fluorodeoxyglucose F18

"Fluorodeoxyglucose F18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)

Descriptor ID	D019788
MeSH Number(s)	D09.254.229.500
Concept/Terms	Fluorodeoxyglucose F18 Fluorodeoxyglucose F18 F18, Fluorodeoxyglucose 18F-FDG Fluorodeoxyglucose F 18 F 18, Fluorodeoxyglucose Fludeoxyglucose F 18 F 18, Fludeoxyglucose Fluorine-18-fluorodeoxyglucose Fluorine 18 fluorodeoxyglucose 18F Fluorodeoxyglucose Fluorodeoxyglucose, 18F 18FDG 2-Fluoro-2-deoxy-D-glucose 2-Fluoro-2-deoxy-D-glucose 2 Fluoro 2 deoxy D glucose 2-Fluoro-2-deoxyglucose 2 Fluoro 2 deoxyglucose

Below are MeSH descriptors whose meaning is more general than "Fluorodeoxyglucose F18".

Chemicals and Drugs [D]
Carbohydrates [D09]
Deoxy Sugars [D09.254]
Deoxyglucose [D09.254.229]
Fluorodeoxyglucose F18 [D09.254.229.500]

Below are MeSH descriptors whose meaning is related to "Fluorodeoxyglucose F18".

Below are MeSH descriptors whose meaning is more specific than "Fluorodeoxyglucose F18".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fluorodeoxyglucose F18" by people in this website by year, and whether "Fluorodeoxyglucose F18" was a major or minor topic of these publications.

Bar chart showing 58 publications over 20 distinct years, with a maximum of 7 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	0	1	1
2002	0	3	3
2003	1	3	4
2004	1	1	2
2005	0	2	2
2006	2	1	3
2008	0	4	4
2009	1	2	3
2010	0	4	4
2011	1	0	1
2012	1	2	3
2013	1	0	1
2014	5	2	7
2015	1	4	5
2016	0	3	3
2017	1	2	3
2018	1	1	2
2019	2	0	2
2021	0	4	4

Below are the most recent publications written about "Fluorodeoxyglucose F18" by people in Profiles.

Martin SS, Muscogiuri E, Burchett PF, van Assen M, Tessarin G, Vogl TJ, Schoepf UJ, De Cecco CN. Tumorous tissue characterization using integrated 18F-FDG PET/dual-energy CT in lung cancer: Combining iodine enhancement and glycolytic activity. Eur J Radiol. 2022 May; 150:110116.

View in: PubMed
Martin SS, van Assen M, Burchett P, Monti CB, Schoepf UJ, Ravenel J, Rieter WJ, Vogl TJ, Costello P, Gordon L, De Cecco CN. Prospective Evaluation of the First Integrated Positron Emission Tomography/Dual-Energy Computed Tomography System in Patients With Lung Cancer. J Thorac Imaging. 2021 Nov 01; 36(6):382-388.

View in: PubMed
Young BD, Moreland H, Oatmen KE, Freeburg LA, Shahab Z, Herzog E, Miller EJ, Spinale FG. Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging. Int Heart J. 2021 Sep 30; 62(5):1096-1105.

View in: PubMed
Bonilha L. Artificial intelligence to enhance the evaluation of refractory epilepsies. Epilepsy Behav. 2021 03; 116:107776.

View in: PubMed
Rahman WT, Wale DJ, Viglianti BL, Townsend DM, Manganaro MS, Gross MD, Wong KK, Rubello D. The impact of infection and inflammation in oncologic 18F-FDG PET/CT imaging. Biomed Pharmacother. 2019 Sep; 117:109168.

View in: PubMed
Viglianti BL, Wale DJ, Ma T, Johnson TD, Bohnen NI, Wong KK, Ky C, Frey KA, Townsend DM, Rubello D, Gross MD. Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging. Biomed Pharmacother. 2019 Apr; 112:108628.

View in: PubMed
Ohtake M, Tateishi K, Murata H, Nagashima Y, Yamanaka S, Yamamoto T. Succinate Dehydrogenase B Subunit-Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [18F]-Fluoro-2-Deoxy-d-Glucose: A Case Report. World Neurosurg. 2018 Jun; 114:47-52.

View in: PubMed
Kocher MR, Sharma A, Garrett-Mayer E, Ravenel JG. Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy. J Comput Assist Tomogr. 2018 Jan/Feb; 42(1):146-150.

View in: PubMed
Goodwin J, Neugent ML, Lee SY, Choe JH, Choi H, Jenkins DMR, Ruthenborg RJ, Robinson MW, Jeong JY, Wake M, Abe H, Takeda N, Endo H, Inoue M, Xuan Z, Yoo H, Chen M, Ahn JM, Minna JD, Helke KL, Singh PK, Shackelford DB, Kim JW. The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat Commun. 2017 05 26; 8:15503.

View in: PubMed
Viglianti BL, Wong KK, Wimer SM, Parameswaran A, Nan B, Ky C, Townsend DM, Rubello D, Frey KA, Gross MD. Effect of hyperglycemia on brain and liver 18F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging. Biomed Pharmacother. 2017 Apr; 88:1038-1045.

View in: PubMed

People

Explore

Similar Concepts

Top Journals